Wobble Genomics Presents Latest Data at ESMO: establishing the robustness of an enhanced liquid biopsy platform for sensitive detection of low-abundance RNA

Contributed by: PR Newswire

Tags

Wobble-Genomics-ESMO

More Like This

Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To Determine Detailed Profiling of HER2 Status in Tissue and Blood

PR Newswire associated0

Wobble Genomics Announces Appointment of Dr. Dietrich A. Stephan as Chairman of the Board of Directors

Hummingbird Diagnostics Publishes Study on RNA Biomarker Methylation in Liquid Biopsies

PR Newswire associated0

WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024

PR Newswire associated0

Lexogen launches Streamlined, Large-scale RNA-Seq Service for Blood Samples

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling

Wistar Scientists Identify Esophageal Cancer Biomarkers

First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer